Melody Han is an Associate at Goldman Sachs, specializing in Commodities CVA Trading since July 2022, after serving as an Analyst in the same department. Previously, Melody worked at Morgan Stanley as a Market Risk Analyst from July 2020 to July 2022, focusing on XVA risk management, and completed a summer internship at Morgan Stanley as a Market Risk Summer Analyst in 2019. Melody's academic background includes a Master's degree in Statistics and Data Science and a Bachelor of Science in Economics and Statistics, both from Carnegie Mellon University, where Melody also served as a Teaching Assistant for various advanced courses. Additionally, Melody gained experience as an Enterprise Actuarial Intern at Highmark Health, contributing to the value-based reimbursement design team.